These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7788974)

  • 1. Racemose neurocysticercosis after chronic meningitis: effect of medical treatment.
    La Mantia L; Costa A; Eoli M; Savoiardo M
    Clin Neurol Neurosurg; 1995 Feb; 97(1):50-4. PubMed ID: 7788974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
    Proaño JV; Madrazo I; García L; García-Torres E; Correa D
    J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis].
    Cohen L; Belec L; Sanson M; Pierrot-Deseilligny C; Signoret JL
    Rev Neurol (Paris); 1992; 148(1):58-61. PubMed ID: 1604116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysticercal meningitis--a pernicious form of neurocysticercosis which responds poorly to praziquantel.
    Joubert J
    S Afr Med J; 1990 May; 77(10):528-30. PubMed ID: 2343353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus: diagnosis and management of neurocysticercosis in children.
    St Geme JW; Maldonado YA; Enzmann D; Hotez PJ; Overturf GD; Schantz PM
    Pediatr Infect Dis J; 1993 Jun; 12(6):455-61. PubMed ID: 8345976
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of sequential prolonged courses of albendazole and praziquantel in recurrent neurocysticercosis].
    Alla P; Carli P; Paris JF; Chagnon A
    Med Trop (Mars); 1996; 56(3):308. PubMed ID: 9026603
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug treatment of neurocysticercosis.
    Garg RK
    Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute meningitis with cerebrospinal fluid eosinophilia: neurocysticercosis].
    Matschke HJ; Flentje B; Lippmann P; Hackebeil C; Abel W
    Psychiatr Neurol Med Psychol (Leipz); 1989 Sep; 41(9):545-9. PubMed ID: 2587668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel.
    Takayanagui OM; Jardim E
    Arch Neurol; 1992 Mar; 49(3):290-4. PubMed ID: 1536632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial.
    Sotelo J; Escobedo F; Penagos P
    Arch Neurol; 1988 May; 45(5):532-4. PubMed ID: 3358706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Praziquantel in the treatment of neurocysticercosis: long-term follow-up.
    Sotelo J; Torres B; Rubio-Donnadieu F; Escobedo F; Rodriguez-Carbajal J
    Neurology; 1985 May; 35(5):752-5. PubMed ID: 3990975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis.
    Cruz M; Cruz I; Horton J
    Southeast Asian J Trop Med Public Health; 1991 Dec; 22 Suppl():279-83. PubMed ID: 1822906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.
    Cruz M; Cruz I; Horton J
    Trans R Soc Trop Med Hyg; 1991; 85(2):244-7. PubMed ID: 1887483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
    Proaño JV; Madrazo I; Avelar F; López-Félix B; Díaz G; Grijalva I
    N Engl J Med; 2001 Sep; 345(12):879-85. PubMed ID: 11565520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases.
    Martinez HR; Rangel-Guerra R; Arredondo-Estrada JH; Marfil A; Onofre J
    J Neurol Sci; 1995 May; 130(1):25-34. PubMed ID: 7650528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tapeworms in the brain--a current problem in Norway?].
    Dietrichs E; Tyssvang T; Aanonsen NO; Bakke SJ; Skullerud K
    Tidsskr Nor Laegeforen; 1994 Oct; 114(26):3089-92. PubMed ID: 7974432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy.
    Overbosch D
    Schweiz Med Wochenschr; 1992 Jun; 122(23):893-8. PubMed ID: 1615299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?
    Carpio A; Santillán F; León P; Flores C; Hauser WA
    Arch Intern Med; 1995 Oct; 155(18):1982-8. PubMed ID: 7575052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocysticercosis.
    Mehndiratta MM; Gupta M
    J Assoc Physicians India; 1990 Nov; 38(11):879-80. PubMed ID: 2079487
    [No Abstract]   [Full Text] [Related]  

  • 20. Albendazole therapy for human neurocysticercosis, a controlled study with computerized tomography and magnetic resonance.
    Escobedo F; Sotelo J; Penagos P; Rodríguez J; del Bruto O
    Acta Leiden; 1989; 57(2):247-54. PubMed ID: 2489003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.